telehealth platform

Hims & Hers Health introduced a six-month Wegovy® subscription at $549/month, a 15% discount on average retail prices, to expand access to prescription weight-loss care. The limited-time offer via telehealth includes consultations, nutritional tools, and progress tracking, leveraging Novo Nordisk’s expanded production. CEO Andrew Dudum emphasized affordability in chronic care, while analysts note the model bridges payer-patient cost gaps. The initiative aligns with a 212% annual rise in metabolic health consultations, reflecting consumer demand for preventive solutions. Promotion runs through June 30, 2025, with eligibility criteria on the company’s platform. Hims & Hers continues offering compounded alternatives and behavioral programs in the $100 billion wellness sector.